Sanofi lays the foundation for Europe’s largest insulin plant
faz.net/aktuell/wirtschaft/unternehmen/sanofi-legt-grundstein-fuer-groesste-insulinanlage-europas-accg-201602124.html

New insulin factory in Frankfurt: largest investment in Sanofi's history: The federal government, the state of Hesse, and the city of Frankfurt are ...
faz.net/aktuell/rhein-main/wirtschaft/neue-insulinfabrik-in-frankfurt-groesste-investition-in-der-sanofi-geschichte-accg-201601874.html

New insulin factory in Frankfurt: largest investment in Sanofi's history
faz.net/aktuell/rhein-main/wirtschaft/neue-insulinfabrik-in-frankfurt-groesste-investition-in-der-sanofi-geschichte-accg-201601874.html

Sanofi's Baptiste de Clarens says the drugmaker is moving beyond importing science, from UAE clinical trials to Saudi-made insulin.

Cancer and serious illnesses in young people: managing the "aftermath": How can we help a young person affected by illness overcome this painful ordeal? Audrey ...
elle.fr/Societe/Sante/Cancer-et-maladies-graves-chez-les-jeunes-gere-l-apres-4676387

This COPD Awareness Month, focus on measurable outcomes. Early identification and evidence-based care can reduce exacerbations and improve lung health ... Show more
A New Era in Airway Disease Management
A New Era in Airway Disease Management
Today, Sanofi broke ground on a new, state-of-the-art insulin production plant at the Höchst Industrial Park. The new plant brings the next generation of ... Show more
Just a moment...
Just a moment...
Sanofi launches €2bn project in Germany to boost EU insulin security: French pharmaceutical giant Sanofi has begun construction of a €2-billion ($2 ...
app.ekkow.com/1484900279221354982

Sanofi: How one of the world's largest insulin production facilities was created in Frankfurt
faz.net/aktuell/rhein-main/wirtschaft/sanofi-wie-in-frankfurt-eine-der-groessten-insulinproduktionen-der-welt-entstand-accg-201316324.html

Sanofi pledges transparency as EU investigates flu vaccine messaging dispute: EU binds Sanofi to commitments ensuring fair vaccine messaging for healthcare ...
brusselstimes.com/eu-affairs/2361112/sanofi-pledges-transparency-as-eu-investigates-flu-vaccine-messaging-dispute

Pharmalittle: We’re reading about Sanofi settling an EU antitrust probe, ‘pharma bro’ Shkreli, and more
statnews.com/pharmalot/2026/10/14/sanofi-settling-european-antitrust-probe-pharma-bro-shkreli/

Paid articlePaywallHall of Fame 2026: Belén Garijo und René Obermann ausgezeichnet: Außergewöhnliche Karrieren, Köpfe und Leistungen: Das manager magazin hat Sanofi-Chefin Belén ...
manager-magazin.de/unternehmen/hall-of-fame-2026-belen-garijo-und-rene-obermann-ausgezeichnet-a-3315c31f-66e2-474f-b664-a657e2d14b1d

Sanofi pays Regeneron up to $8B to expand immunology alliance: Regeneron will receive $1 billion upfront, with up to $7 billion more in milestones ...
dlvr.it/TVlJNj

During Rheumatoid Arthritis Awareness Month, explore education designed to help clinicians move beyond reactive care and support better long-term outcomes with ... Show more
Immunology Learning Nexus
Immunology Learning Nexus
Explore new content focused on recognizing uncontrolled moderate to severe asthma and identifying when referral or treatment escalation may be appropriate ... Show more
A New Era in Airway Disease Management
A New Era in Airway Disease Management
Sanofi is paying Regeneron up to $8 billion to expand their immunology alliance: Regeneron will receive $1 billion upfront, with up to $7 billion more in ...
qz.com/sanofi-regeneron-immunology-alliance-expansion-8-billion-100226

Russian forces struck warehouses used by one of Ukraine’s largest pharmaceutical distributors outside Kyiv, raising fears of disruptions to medicine supplies ... Show more
Index of /
Index of /

Dividend income at risk? 8 stocks with inconsistent dividend payout: Indian Oil, Sanofi India, UTI AMC, and more
livemint.com/market/stock-market-news/dividend-income-at-risk-8-stocks-with-inconsistent-dividend-payout-indian-oil-sanofi-india-uti-amc-and-more-11790768058400.html

On this Health Awareness Day, recognize the role of glycemic control in diabetes and well-being. CGM improves detection of glucose fluctuations ... Show more
The CGM Toolbox
The CGM Toolbox
Next shock for Novo Nordisk shareholders: This is why the stock is plummeting: Novo Nordisk lowers growth expectations and warns of patent expirations ...
boerse-online.de/nachrichten/aktien/naechster-schock-fuer-novo-nordisk-aktionaere-darum-rauscht-die-aktie-ab-20409207.html

Pharmalittle: We’re reading about FDA hiring delays, a new Bavarian Nordic CEO, and more
statnews.com/pharmalot/2026/09/17/fda-hiring-delays-bavarian-nordic-appoints-ceo/

Paid articlePaywallSanofi inaugurates Toronto facility that will produce seasonal flu vaccines for Canadians
theglobeandmail.com/business/economy/article-sanofi-toronto-facility-seasonal-flu-vaccine/
Pharmaceutical company: Pharmaceutical giant Sanofi invests in German Cheplapharm
manager-magazin.de/unternehmen/pharma/sanofi-pharmariese-sanofi-steigt-bei-deutscher-cheplapharm-ein-a-c11beee4-3067-417d-802c-88f5677d257d

Novartis Just Cruised Past A Buy Point Amid Its Roche, Sanofi Rivalry: Novartis stock surged early Tuesday after its experimental multiple sclerosis treatment ...
investors.com/news/technology/novartis-stock-multiple-sclerosis-treatment/

New Sanofi factory in Frankfurt: Construction begins in October: The EU Commission has approved state aid for the Sanofi factory in the Höchst Industrial Park ...
faz.net/aktuell/rhein-main/frankfurt/neue-sanofi-fabrik-in-frankfurt-baubeginn-im-oktober-accg-201206112.html

Green light for a billion-euro investment in Frankfurt-Höchst: The EU Commission has approved state investment aid for Sanofi's new insulin plant in the ... Show more
EU Commission approves Sanofi investment for modern insulin plant | City of Frankfurt am Main
EU Commission approves Sanofi investment for modern insulin plant | City of Frankfurt am Main
EU clears €400 million in German state aid for Sanofi insulin plant: The European Commission has cleared €400 million ($464 million) in German state aid for ...
app.ekkow.com/1470102843684012161

The FDA has approved updated COVID-19 vaccines from Moderna, Pfizer-BioNTech and Novavax-Sanofi for the 2026-27 season. ⬇️🔗
Read more: FDA approves updated COVID vaccines targeting XFG ‘Stratus’ variant
Take a global view of myasthenia gravis management. Compare evolving guideline recommendations, uncover practical clinical applications ... Show more
Autoimmune Disorders
Autoimmune Disorders
Gain practical strategies for managing CRSwNP beyond repeated oral steroid use. Learn how current evidence can help identify uncontrolled disease ... Show more
A New Era in Airway Disease Management
A New Era in Airway Disease Management
Sanofi to lay off 229 workers in Mass., a year after $9.1B Blueprint Medicines acquisition
bostonglobe.com/2026/08/17/business/sanofi-blueprint-layoffs-massachusetts/

Paid articlePaywallPharmalittle: We’re reading about a Sanofi drug shortage, a Jazz Pharma deal, and more
statnews.com/pharmalot/2026/08/10/sanofi-drug-shortage-jazz-pharma-deal/

Paid articlePaywallA shortage of two Sanofi medicines for Pompe disease rattles patients: Sanofi is experiencing shortages of two medicines for Pompe disease, alarming patient ...
statnews.com/pharmalot/2026/08/09/sanofi-pompe-disease-drug-shortage-myozyme-nexviazyme/

Paid articlePaywallAdani Ports, Radico, KFin among 6 top stock ideas for Aug by Motilal Oswal: Motilal Oswal Wealth Management Research Desk recommends 2 stocks each from the ...
business-standard.com/markets/news/adani-ports-radico-kfin-among-6-top-stock-ideas-for-aug-by-motilal-oswal-126080300065_1.html
Regeneron: Stock price turbocharges: Regeneron exceeded expectations with revenue of USD 4.29 billion and record profits at Dupixent and EYLEA ...
deraktionaer.de/artikel/aktien/megatrend-folger-regeneron-zuendet-den-kursturbo-20406138.html

Kalshi Will Let Traders Bet on FDA Drug Approvals Despite Critics' Insider Trading Warnings - Sanofi (NAS
benzinga.com/markets/prediction-markets/26/07/60506835/kalshi-will-let-traders-bet-on-fda-drug-approvals-despite-critics-insider-trading-warnings

Despite positive study data: Sanofi pulls the plug: Sanofi is ending the development of amlitelimab for moderate to severe atopic dermatitis ...
wallstreet-online.de/nachricht/21148256-strategische-neuausrichtung-trotz-positiver-studiendaten-sanofi-reissleine

Sanofi: Belén Garijo focuses on innovation and growth: Belén Garijo has made it clear that a new wind is blowing at Sanofi under her leadership ...
faz.net/aktuell/wirtschaft/unternehmen/sanofi-belen-garijo-setzt-auf-innovation-und-wachstum-201079405.html

Explore our new curriculum featuring expert-led insights on the latest clinical advances shaping a new era in airway disease management ... Show more
A New Era in Airway Disease Management
A New Era in Airway Disease Management
Sanofi is scrapping its once-touted eczema drug in a new CEO pipeline overhaul: The French drugmaker said the drug would not represent a meaningful improvement ...
qz.com/sanofi-amlitelimab-eczema-drug-scrapped-ceo-pipeline-072426

Pharmalittle: We're reading about an RFK Jr. push against psychiatric meds, a Sanofi blood cancer drug, and more
statnews.com/pharmalot/2026/07/13/rfk-push-against-ssri-antidepressants-sanofi-blood-cancer-drug/

Paid articlePaywallUS FDA approves Sanofi's wearable injector form of blood cancer drug: The U.S. Food and Drug Administration said on Friday it has approved a wearable form of ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-sanofis-wearable-injector-form-blood-cancer-drug-2026-07-10/

Drugmaker faces EU scrutiny over alleged flu vaccine smear campaign: The EU is investigating allegations that a major drugmaker misled health-care professionals ...
brusselstimes.com/eu-affairs/2221094/drugmaker-faces-eu-scrutiny-over-alleged-flu-vaccine-smear-campaign

Sanofi Multiple Sclerosis Drug Gets EU Approval: The authorization of Cenrifki for the treatment of secondary progressive multiple sclerosis without relapses ...
on.wsj.com/44v9NEN
Sanofi names new R&D head as it tries to jumpstart pipeline: The move to appoint a new R&D head comes as Sanofi faces pressure to develop more blockbusters ...
statnews.com/2026/06/22/sanofi-paulo-fontoura-houman-ashrafian-research-and-development/

Paid articlePaywallSanofi, An Argenx Rival, Bites The Dust — But A Third Biotech Took The Biggest Hit
investors.com/news/technology/sanofi-stock-dianthus-therapeutics-argenx-cidp-treatment/

Lilly’s Ajax acquisition may have been worth it: STAT's biotech news roundup today includes a syphilis drug shortage, Sanofi's diabetes drug approval ...
statnews.com/2026/06/15/biotech-news-lilly-ajax-acquisition-may-have-been-worth-it/

Paid articlePaywallPharmalittle: We’re reading about Pfizer’s emergency penicillin program, a Sanofi diabetes drug, and more
statnews.com/pharmalot/2026/06/15/pfizer-emergency-penicillin-program-sanofi-diabetes-drug/

Paid articlePaywallFDA approves expanded use of Sanofi's type 1 diabetes drug: The U.S. Food and Drug Administration said on Friday it has approved the expanded use of Sanofi's ...
reuters.com/legal/litigation/fda-approves-sanofis-drug-stage-3-type-1-diabetes-children-2026-06-12/

Dividend stocks: Tata Tech, Sanofi Consumer, 20 others go ex-date next week: Upcoming Dividend stocks next week: Among the companies, Sanofi Consumer Healthcare ...
business-standard.com/markets/news/upcoming-dividend-stocks-tata-tech-sanofi-consumer-20-others-go-ex-date-next-week-126061200121_1.html
Pharmalittle: We’re reading about employer coverage of obesity drugs, another Sanofi setback, and more
statnews.com/pharmalot/2026/06/11/employer-overage-of-obesity-drugs-another-sanofi-setback/

Paid articlePaywallSanofi ends Phase 3 riliprubart trial after weak interim results: Biopharmaceutical company Sanofi will stop a Phase 3 trial of its drug riliprubart for a rare ...
reuters.com/legal/litigation/sanofi-ends-phase-3-riliprubart-trial-after-weak-interim-results-2026-06-10/

Sanofi to Stop Late-Stage Study of Immune-Disorder Drug: The study concluded that riliprubart was unlikely to deliver sufficient efficacy
wsj.com/health/pharma/sanofi-to-stop-late-stage-study-of-immune-disorder-drug-1f05296c
Paid articlePaywall"We measure success in patient numbers": Markus Isenmann, Managing Director for Austria and Switzerland and Head of the Specialty Care division at Sanofi: a ...
diepresse.com/26122609/wir-messen-erfolg-in-patientenzahlen

This Small Biotech — Taking On AbbVie, Novartis And Sanofi — Just Catapulted Into A Breakout
investors.com/news/technology/biotech-stock-avalo-therapeutics-hs-treatment/

Merck relies on veteran: Kai Beckmann takes over as CEO: The Darmstadt-based pharmaceutical | And the technology group is getting a new CEO ...
op-online.de/wirtschaft/merck-setzt-auf-urgestein-kai-beckmann-uebernimmt-chefposten-zr-94287299.html

Sanofi Leans On Dupixent For First-Quarter Beat A Week Ahead Of New CEO: Sanofi stock jumped Thursday after the French pharma beat first-quarter forecasts on the ...
investors.com/news/technology/sanofi-stock-sanofi-earnings-q1-2026/

From Merck to Sanofi: A Snake Pit Rather Than Retirement, Ms. Garijo?: After five years at the helm of Merck, Belén Garijo is stepping down. But instead of ...
faz.net/aktuell/wirtschaft/unternehmen/von-merck-zu-sanofi-lieber-schlangengrube-als-ruhestand-frau-garijo-200766615.html

Q4 result: Maruti Suzuki, Bandhan Bank, Castrol, and 42 more on April 28: Q4FY26 company results: Firms including AWL Agri Business, REC, Ceat, Dalmia Bharat ...
business-standard.com/companies/quarterly-results/q4-result-maruti-suzuki-bandhan-bank-castrol-and-42-more-on-april-28-126042800149_1.html
Stocks to Watch today: Coal India, Trent, Punjab & Sind Bk, Adani Total Gas: Stocks to Watch today, April 28, 2026: Coal India, Trent, City Union Bank ...
business-standard.com/markets/news/stocks-to-watch-today-coal-india-trent-punjab-sind-bk-adani-total-gas-126042800118_1.html
Sanofi MS drug gets positive review in Europe following FDA: Today's biotech news includes news on Sanofi's MS drug, Regeneron's pricing deal with ...
statnews.com/2026/04/24/sanofi-ms-drug-europe-reveiew-regeneron-white-house/

Paid articlePaywallSAP, Sanofi and Nestlé gain ground: SAP, Nestlé and Sanofi exceed market expectations with strong quarterly results, despite geopolitical uncertainties ...
deraktionaer.de/artikel/indizes/sap-sanofi-und-nestl-ziehen-an-20399677.html

Gujarat Themis Biosyn zooms 14% on acquiring Sanofi's TB drug portfolio: The buying on the counter came after Gujarat Themis Biosyn signed an Asset Purchase ...
business-standard.com/markets/news/gujarat-themis-biosyn-zooms-14-percent-on-aacquiring-sanofi-s-tb-drug-portfolio-126042400508_1.html
Sanofi research priorities in flux as new CEO logs in : Today's biotech news includes a promising gene therapy for deafness, all eyes on Erasca, and RFK Jr ...
statnews.com/2026/04/23/biotech-news-sanofi-research-priorities-in-flux-with-new-ceo/

Paid articlePaywallEuropean stocks to open in negative territory as oil prices gain : European stocks are expected to open in negative territory on Thursday as regional market ...
cnbc.com/2026/04/23/european-markets-stoxx-600-ftse-dax-cac-iran-latest-oil-prices.html

LOOK: PhilCare President and CEO Jaeger L. Tanco, PhilCare EVP Medical Director Dr. Eilyn Ayuste, Sanofi General Manager for Vaccines for Southeast Asia & ... Show more
Merck, Sanofi are latest companies to add medications to TrumpRx: Merck and Sanofi are the latest drugmakers to join TrumpRx.gov, offering steep discounts on ...
foxbusiness.com/politics/merck-sanofi-latest-companies-add-medications-trumprx

Every Aussie should check their super now: It’s the $4.5 trillion safety net that’s been the envy of the world for 34 years - but a news.com ...
news.com.au/finance/superannuation/perfect-storm-threatening-australias-45-trillion-secret-weapon/news-story/6e948db0aca95ff4fe9c7182cb9ea290
From Lungs To Nasal Polyps: Sanofi Finds Success With 2-in-1 Inflammation Blocker - Sanofi (NASDAQ:SNY)
benzinga.com/markets/biotech/26/04/51674881/from-lungs-to-nasal-polyps-sanofi-finds-success-with-2-in-1-inflammation-blocker

EU regulator backs Sanofi's injectable version of blood cancer drug: French drugmaker Sanofi said on Friday the European Medicines Agency has recommended the ...
reuters.com/business/healthcare-pharmaceuticals/eu-regulator-backs-sanofis-injectable-version-blood-cancer-drug-2026-03-27/

Statement on the recently submitted recommendations of the Finance Commission for Health (FKG)
presseportal.de/pm/71182/6247742
Sanofi launches innovation and operation centre in China: French drugmaker Sanofi launched an innovation and operation centre in the southwestern Chinese ...
reuters.com/business/healthcare-pharmaceuticals/sanofi-launches-innovation-operation-centre-china-2026-03-20/

From basic research to the development of new antibodies - | Drug research at Sanofi
presseportal.de/pm/71182/6243155
Fear of lobbyists? Government demands "vow of silence" on healthcare reform: Instead of cutting healthcare spending, the SPD wants to squeeze even more money out ...
berliner-zeitung.de/politik-gesellschaft/angst-vor-lobbyisten-regierung-fordert-schweigegeluebde-bei-gesundheitsreform-li.10023243

Paid articlePaywallSino Biopharm unit licenses blood cancer drug to Sanofi for up to $1.53 bln: Hong Kong-listed Sino Biopharmaceutical said on Wednesday its unit has signed an ...
reuters.com/business/healthcare-pharmaceuticals/sino-biopharm-unit-licenses-blood-cancer-drug-sanofi-up-153-bln-2026-03-03/

Ontario’s order to limit height near Sanofi plant kills Toronto highrise project, developer says
thestar.com/real-estate/ontarios-order-to-limit-height-near-sanofi-plant-kills-toronto-highrise-project-developer-says/article_17b28fb1-e3ab-4c06-9846-eccb3a0ee495.html
